Analysis of a clinical case of primary hyperparathyroidism in combination with parathyroid adenoma and nodular goiter
https://doi.org/10.20340/vmi-rvz.2021.1.CLIN.5
Abstract
The analysis of a clinical case of primary hyperparathyroidism in combination with parathyroid adenoma and nodular goiter is presented.
About the Authors
S. N. Styazhkina
Izhevsk State Medical Academy
Russian Federation
Russian Federation
Izhevsk
A. V. Ledneva
Izhevsk State Medical Academy
Russian Federation
Russian Federation
Izhevsk
V. P. Byvaltseva
Izhevsk State Medical Academy
Izhevsk
M. A. Michurina
Izhevsk State Medical Academy
Izhevsk
References
1. 1 Farkhutdinova L.M. Pervichnyy giperparatireoz: sovremennyye predstavleniya i klinicheskoye nablyudeniye. Arkhiv vnutrenney meditsiny. 2020;10(2):52. (In Russ).
2. 2 Klinicheskiye rekomendatsii. Pervichnyy giperparatireoz (utv. Minzdravom Rossii). Moscow: GEOTAR-Media, 2016. 73 s. (In Russ).
3. 3 Dedov I.I., Vasilyeva T.O., Rozhinskaya L.YA., Mokrysheva N.G. Epidemiologiya pervichnogo giperparatireoza. Problemy endokrinologii. 2010;56(5). (In Russ).
4. 4 Borsuk A.D. Pervichnyy giperparatireoz (obzor literatury). Problemy zdorovya i ekologii. 2013;4(38). (In Russ).
5. 5 Epidemiology of Primary Hyperparathyroidism in Europe – report commissioned by Amgen. The Mattson Jack Group. Ref Type: Report. 2003.
6. 6 Hedbäck G., Oden A. Death risk factor analysis in primary hyperparathyroidism. European journal of clinical investigation. 1998;28(12):1011–1018. https://doi.org/10.1046/j.1365-2362.1998.00387.x
7. 7 Blichert-Toft M., Mollerup C.L., Feldt-Rasmussen U.F., Daugaard H., Engel U.H. Primary hyperparathyroidism. An underdiagnosed disease in Denmark? Ugeskrift for laeger. 1993;155(11):765–769.
Supplementary files
Review
For citations:
Styazhkina S.N., Ledneva A.V., Byvaltseva V.P., Michurina M.A. Analysis of a clinical case of primary hyperparathyroidism in combination with parathyroid adenoma and nodular goiter. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2021;(1):53-57. (In Russ.) https://doi.org/10.20340/vmi-rvz.2021.1.CLIN.5
Views:
391
Email this article 